Major advances in autoimmune and cancer therapies, vaccine successes, and critical drug shortages dominate today's health news, while healthcare workforce stress and emerging comorbidity risks gain attention.

Advanced bispecific T-cell engager therapies are achieving deep tissue clearance in autoimmune patients, driving long-term drug-free remissions through nonconventional B-cell depletion that may reset autoimmune memory in previously refractory cases.

Record-breaking medicine shortages are stretching pharmacies to their limits, prompting health leaders to call for an emergency taskforce to address what pharmacists describe as among the worst supply crises ever seen.

New adenoviral-based immunotherapy has improved disease-free survival in men with intermediate- or high-risk localized prostate cancer, though experts expressed some reservations about the approach's broader applicability.

The HPV vaccine has prevented nearly 200 cervical cancer deaths in England, but falling vaccination rates threaten to stall further progress in reducing cervical cancer mortality.

Sleep disorders have emerged as a significant risk factor for sudden unexpected death in epilepsy, with comorbid primary sleep disorders also associated with increased all-cause mortality and accidents in epilepsy patients.

GLP-1 medications show promise in treating metabolic symptoms of PCOS, including overweight and diabetes, offering a therapeutic option for patients with this common endocrine disorder.

Physician anger and burnout are widespread problems affecting healthcare delivery quality, with experts emphasizing that the issue doesn't have to be inevitable if properly addressed.

New genetic, metabolic, and immune research indicates hidradenitis suppurativa is more than a skin disease, supporting the need for coordinated multidisciplinary care approaches across specialties.